These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38773300)

  • 1. Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome.
    Kobayashi M; Miyauchi A; Jimbo EF; Oishi N; Aoki S; Watanabe M; Yoshikawa Y; Akiyama Y; Yamagata T; Osaka H
    Sci Rep; 2024 May; 14(1):11561. PubMed ID: 38773300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Analogues of Aporphine Alkaloids.
    Ge YC; Wang KW
    Mini Rev Med Chem; 2018; 18(19):1590-1602. PubMed ID: 29692245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine is a potent inhibitor of ferroptosis independent of dopaminergic receptors.
    Miyauchi A; Watanabe C; Yamada N; Jimbo EF; Kobayashi M; Ohishi N; Nagayoshi A; Aoki S; Kishita Y; Ohtake A; Ohno N; Takahashi M; Yamagata T; Osaka H
    Sci Rep; 2024 Feb; 14(1):4820. PubMed ID: 38413694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease.
    Miyauchi A; Kouga T; Jimbo EF; Matsuhashi T; Abe T; Yamagata T; Osaka H
    Mitochondrion; 2019 Nov; 49():111-120. PubMed ID: 31356884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of some aporphine derivatives related to apomorphine.
    Saari WS; King SW
    J Med Chem; 1974 Oct; 17(10):1086-90. PubMed ID: 4472802
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of aporphine isomers on rat prolactin.
    Baldessarini RJ; Campbell A; Ben-Jonathan N; Ellingboe J; Zong R; Neumeyer JL
    Neurosci Lett; 1994 Aug; 176(2):269-71. PubMed ID: 7830962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
    Kelly PH; Miller RJ; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 2-thioether-substituted apomorphines as potent and selective dopamine D₂ receptor agonists.
    Reinart R; Gyulai Z; Berényi S; Antus S; Vonk A; Rinken A; Sipos A
    Eur J Med Chem; 2011 Jul; 46(7):2992-9. PubMed ID: 21550699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.
    Lal S; Sourkes TL; Missala K; Belendiuk G
    Eur J Pharmacol; 1972 Oct; 20(1):71-9. PubMed ID: 4674034
    [No Abstract]   [Full Text] [Related]  

  • 11. Biophysical and in silico interaction studies of aporphine alkaloids with Malonyl-CoA: ACP transacylase (FabD) from drug resistant Moraxella catarrhalis.
    Kumar V; Sharma A; Pratap S; Kumar P
    Biochimie; 2018 Jun; 149():18-33. PubMed ID: 29604333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.
    Wang FX; Zhu N; Zhou F; Lin DX
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT and alpha-adrenoceptor antagonist effect of four benzylisoquinoline alkaloids on rat aorta.
    Catret M; Ivorra MD; D'Ocón MP; Anselmi E
    J Pharm Pharmacol; 1998 Mar; 50(3):317-22. PubMed ID: 9600725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D(2) activity of R-(-)-apomorphine and selected analogs: a microdialysis study.
    Rodenhuis N; Dijkstra D; de Boer P; Vermeulen ES; Timmerman W; Wikström HV
    Eur J Pharmacol; 2000 Jan; 387(1):39-45. PubMed ID: 10633158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Permeable Succinate Increases Mitochondrial Membrane Potential and Glycolysis in Leigh Syndrome Patient Fibroblasts.
    Bakare AB; Rao RR; Iyer S
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
    [No Abstract]   [Full Text] [Related]  

  • 17. Aporphines and Parkinson's Disease: Medical Tools for the Future.
    Fazel Nabavi S; Uriarte E; Rastrelli L; Modak B; Sobarzo-Sánchez E
    Curr Top Med Chem; 2016; 16(17):1906-9. PubMed ID: 26845550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine induces mitochondrial-dysfunction-dependent apoptosis in choriocarcinoma.
    Lee JY; Ham J; Lim W; Song G
    Reproduction; 2020 Sep; 160(3):367-377. PubMed ID: 32520723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
    Lincoln L; Fisher R; Jackson MJ; Jenner P; Neumeyer J; Sromek AW; Lees AJ; Rose S
    Mov Disord; 2016 Sep; 31(9):1381-8. PubMed ID: 27133947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.